Expression and mechanism of mammalian target of rapamycin in age-related renal cell senescence and organ aging

Mechanisms of Ageing and Development

Volumn 130, Issue 10, 2009, Pages 700-708

  Zhuo, Li ^a,b   Cai, Guangyan ^a   Liu, Fuyou ^b   Fu, Bo ^a   Liu, Weiping ^a   Hong, Quan ^a   Ma, Qiang ^a   Peng, Youming ^b   Wang, Jianzhong ^a   Chen, Xiangmei ^a  

^a Department of Nephrology   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cellular senescence; HDFs; mTOR

Indexed keywords

BETA GALACTOSIDASE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL AGING; CELL COUNT; CELL CYCLE G1 PHASE; CELL VOLUME; CONTROLLED STUDY; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; KIDNEY; KIDNEY CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENESCENCE;

AGE FACTORS; AGING; ANIMALS; CELL AGING; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY; MALE; MESANGIAL CELLS; PHOSPHORYLATION; PROTEIN KINASES; RATS; RATS, WISTAR; RNA, MESSENGER; SIROLIMUS; TIME FACTORS;

MAMMALIA; RATTUS;

EID: 70349433524     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2009.08.005     Document Type: Article

References (49)

1. Abrass C.K., Adcox M.J., and Raugi G.J. Aging-associated changes in renal extracellular matrix. Am. J. Pathol. 146 (1995) 742-752
2. Amin R.M., Hiroshima K., Miyagi Y., Kokubo T., Hoshi K., Fujisawa T., and Nakatani Y. Role of the PI3K/Akt, mTOR, and STK11/LKB1 pathways in the tumorigenesis of sclerosing hemangioma of the lung. Pathol. Int. 58 (2008) 38-44
3. Atadja P., Wong H., Veillete C., and Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp. Cell Res. 217 (1995) 205-216
4. Baylis C., and Corman B. The aging kidney: insights from experimental studies. J. Am. Soc. Nephrol. 9 (1998) 699-709
5. Bell E., Marek L.F., Levinstone D.S., Merrill C., Sher S., Young I.T., and Eden M. Loss of division potential in vitro: aging or differentiation?. Science 202 (1978) 1158-1163
6. Bell R., Hubbard A., Chettier R., Chen D., Miller J.P., Kapahi P., Tarnopolsky M., Sahasrabuhde S., Melov S., and Hughes R.E. A human protein interaction network shows conservation of aging processes between human and invertebrate species. PLoS Genet. 5 (2009) e1000414
7. Bjelogrlić S.K., Srdić T., and Radulović S. Mammalian target of rapamycin is promising target for novel therapeutic strategy against cancer. J. BUON 11 (2006) 267-276
8. Blagosklonny M.V. Cell senescence: hypertrophic arrest beyond restriction point. J. Cell Physiol. 209 (2006) 592-597
9. Bonegio R.G., Fuhro R., Wang Z., Valeri C.R., Andry C., Salant D.J., and Lieberthal W. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J. Am. Soc. Nephrol. 16 (2005) 2063-2072
10. Chang B.D., Broude E.V., Dokmanovic M., Zhu H., Ruth A., Xuan Y., Kandel E.S., Lausch E., Christov K., and Roninson I.B. A senescence-like phenotype distinguishes tumour cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59 (1999) 3761-3767
11. Chen J.K., Chen J., Neilson E.G., and Harris R.C. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J. Am. Soc. Nephrol. 16 (2005) 1384-1391
12. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., and Pereira S.O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Nat. Acad. Sci. U.S.A. 92 (1995) 9363-9367
13. Drenan R.M., Liu X.Y., Bertram P.G., and Zheng X.F. FKBP12-Rapamying-associated protein or mammalian target of Rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the golgi apparatus. J. Biol. Chem. 279 (2004) 772-779
14. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumour suppression. Cell 75 (1993) 817-825
15. Floege J., Hackmann B., Kliem V., Kriz W., Alpers C.E., Johnson R.J., Kühn K.W., Koch K.M., and Brunkhorst R. Age related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int. 51 (1997) 230-242
16. Frances C.L., Andreas S., Sabine B., Christiane B., and Rolf M. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J. Cell Sci. 105 (1993) 123-133
17. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science 249 (1990) 1129-1133
18. Hansen M., Chandra A., Mitic L.L., Onken B., Driscoll M., and Kenyon C. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet. 4 (2008) e24
19. Hansen M., Taubert S., Crawford D., Libina N., Lee S.J., and Kenyon C. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 6 (2007) 95-110
20. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961) 585-621
21. Huynh H., Chow K.P., Soo K.C., Toh H.C., Choo S.P., Foo K.F., Poon D., Ngo V.C., and Tran E. RAD001 (everolimus) inhibits tumor growth in xenograft models of human hepatocellular carcinoma. J. Cell. Mol. Med. 13 (2009) 1371-1380
22. Inoki K., and Guan K.L. Complexity of the TOR signaling network. Trends Cell Biol. 16 (2006) 206-212
23. Kaeberlein M., Wilson Powers R., Steffen K.K., Westman E.A., Hu D., Dang N., Kerr E.O., Kirkland K.T., Fields S., and Kennedy B.K. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310 (2005) 1193-1196
24. Kapahi P., Zid B.M., Harper T., Koslover D., Sapin V., and Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 14 (2004) 885-890
25. Li Z., Chen X., Xie Y., Shi S., Feng Z., Fu B., Zhang X., Cai G., Wu C., Wu D., and Gu Y. Expression and significance of integrin-linked kinase in cultured cells, normal tissue, and diseased tissue of aging rat kidneys. J. Gerontol. A Biol. Sci. Med. Sci. 59 (2004) 984-996
26. Martin D.E., and Hall M.N. The expanding TOR signaling network. Curr. Opin. Cell Biol. 17 (2005) 158-166
27. Martin D.E., Soulard A., and Hall M.N. TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1. Cell 119 (2004) 969-979
28. McCormick A., and Campisi J. Cellular aging and senescence. Curr. Biol. 3 (1991) 230-234
29. McConnell B.B., Starborg M., Brookes S., and Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8 (1998) 351-354
30. Nijland M.J., Schlabritz-Loutsevitch N.E., Hubbard G.B., Nathanielsz P.W., and Cox L.A. Non-human primate fetal kidney transcriptome analysis indicates mammalian target of rapamycin (mTOR) is a central nutrient-responsive pathway. J. Physiol. 579 (2007) 643-656
31. Noda A., Ning Y., Venable S.F., Pereira-Smith O.M., and Smith J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211 (1994) 90-98
32. Pan K.Z., Palter J.E., Rogers A.N., Olsen A., Chen D., Lithgow G.J., and Kapahi P. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 6 (2007) 111-119
33. Piguet A.C., Semela D., Keogh A., Wilkens L., Stroka D., Stoupis C., St-Pierre M.V., and Dufour J.F. Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma. J. Hepatol. 49 (2008) 78-87
34. Powers III R.W., Kaeberlein M., Caldwell S.D., Kennedy B.K., and Fields S. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 20 (2006) 174-184
35. Raslova H., Baccini V., Loussaief L., Comba B., Larghero J., Debili N., and Vainchenker W. Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation. Blood 107 (2006) 2303-2310
36. Sabatini D.M. mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 6 (2006) 729-734
37. INK4a. Cell 88 (1997) 593-602
38. Sherr C.J. Principles of tumor suppression. Cell 116 (2004) 235-246
39. Sigal S.H., Rajvanshi P., Gorla G.R., and Sokhi R.P. Partial hepatectomy induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am. J. Physiol. 276 (1999) G1260-G1272
40. Sinuani I., Averbukh Z., Gitelman I., Raporort M.J., Sandbank J., Albeck M., Sredni B., and Weissqarten J. Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-beta secretion: effect of the immunomodulator AS101 on this process. Am. J. Physiol. Renal. Physiol. 291 (2006) F384-394
41. Syntichaki P., Troulinaki K., and Tavernarakis N. eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans. Nature 445 (2007) 922-926
42. Terada N., Takase K., Papst P., Nairn A.C., and Gelfand E.W. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes. J. Immunol. 155 (1995) 3418-3426
43. Thomas S.E., Anderson S., Gordon K.L., Oyama T.T., Shankland S.J., and Johnson R.J. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J. Am. Soc. Nephrol. 9 (1998) 231-242
44. CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ. 9 (1998) 139-146
45. Wiggins J.E., Goyal M., Sanden S.K., Wharram B.L., Shedden K.A., Misek D.E., Kuick R.D., and Wiggins R.C. Podocyte hypertrophy, "adaptation" and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J. Am. Soc. Nephrol. 16 (2005) 2953-2966
46. Wong H., and Riabowol K. Differential CDK-inhibitor gene expression in aging human diploid fibroblasts. Exp. Gerontol. 31 (1996) 311-325
47. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 (2006) 471-484
48. Yang Y., Wang J., Qin L., Shou Z., Zhao J., Wang H., Chen Y., and Chen J. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am. J. Nephrol. 27 (2007) 495-502
49. Yitzhaki S., Barnea A., Keysary A., and Zahavy E. New approach for serological testing for leptospirosis by using detection of leptospira agglutination by flow cytometry light scatter analysis. J. Clin. Microbiol. 42 (2004) 1680-1685